Safety and Quality of Life Study of Dexlansoprazole Modified Release Formulation to Treat Heartburn
NCT00255190
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
591
Enrollment
INDUSTRY
Sponsor class
Conditions
Gastroesophageal Reflux Disease
Interventions
DRUG:
Dexlansoprazole MR
DRUG:
Dexlansoprazole MR
Sponsor
Takeda